CANTON, Mass. (PRWEB)
September 01, 2020
Universal Sequencing Technology Corporation (‘UST’), a developer of Next Generation Sequencing (NGS) technologies, today is proud to announce a commercial relationship with Golden Gateway Partners, LLC for the exclusive distribution in Australia of the game changing TELL-Seq WGS Library Prep Kit.
The TELL-Seq kit is the linked-read alternative to long-read DNA sequencing. Customers in North America, Europe, Asia, and Australia are currently using the kit to turn their short-read DNA sequencers into long-read sequencers. The kit can be used with very low input amounts of DNA for de novo DNA sequencing applications as well as elucidating genomic structural variations and genome phasing.
Universal Sequencing Technology was founded by next generation DNA sequencing veterans from Roche/454. The TELL-Seq WGS Library Preparation kit is the first product launched from UST with multiple products in the pipeline. The underlying technology behind the TELL-Seq, which stands for Transposase Enzyme Linked Long-read Sequencing, was invented by Chief Science Officer Zhoutao “Tom” Chen.
Golden Gateway Partners are experienced in assisting startup life science tools companies to grow commercially in the Asia Pacific region. With a unique business model that enables a single distribution channel across the entire Asia Pacific region combined with UST’s breakthrough technology, it created an ideal opportunity to develop a partnership.
“We are delighted to be working with Golden Gateway Partners,” stated Dr. Andrew Bond, Universal Sequencing’s Head of Commercial Strategy. “They know the genomics and sequencing market in Asia and Australia and we know TELL-Seq will be a great fit for many researchers in Australia”.
“Our mission is to bring new and innovative technologies to emerging markets throughout Asia”, explained Matthew Levy, Managing Director at Golden Gateway Partners. “By using the chemistry developed by UST, researchers can now get much more from their investment in NGS instruments”.
ABOUT UNIVERSAL SEQUENCING TECHNOLOGY
Universal Sequencing Technology was established by a group of NGS technology veterans. UST is dedicated to the development of the most advanced, cost-effective, long-read, DNA sequencing technologies. Currently, UST has filed a total of 25 provisional patent filings covering linked, long-read library preparation chemistry and groundbreaking 3rd generation DNA sequencing technology. UST is poised to lead the next wave of DNA sequencing innovations.
ABOUT GOLDEN GATEWAY PARTNERS
Golden Gateway Partners, LLC is your source for advancing into new markets through international expansion. Whether your company is new to international business or manages existing operations, the team at Golden Gateway Partners, LLC can assist with the full line of activities necessary to grow your business overseas.
For Universal Sequencing Technology Corp. Media Inquires
Name: Andrew Bond
For Golden Gateway Partners, LLC Media Inquiries
Name: Thao Fisher
Share article on social media or email: